Emily Leproust
Chief Executive Officer bei TWIST BIOSCIENCE CORPORATION
Vermögen: 18 Mio $ am 31.03.2024
Profil
Emily Marine Leproust gründete Twist Bioscience Corp. und Petri. Dr. Leproust hat die Position des Chairman, President & Chief Executive Officer für Twist Bioscience Corp. inne. Sie ist auch im Vorstand von CM Life Sciences, Inc. Zuvor war Dr. Leproust Chairman bei Nektar Therapeutics und Director-Applications & Chemistry bei Agilent Technologies, Inc. Dr. Leproust promovierte an der University of Houston und erwarb einen Abschluss an der Lyon School of Industrial Chemistry.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
TWIST BIOSCIENCE CORP.
0,89% | 02.04.2024 | 514 149 ( 0,89% ) | 18 Mio $ | 31.03.2024 |
21.07.2023 | 2 524 ( 0,01% ) | 23 044 $ | 31.03.2024 |
Aktive Positionen von Emily Leproust
Unternehmen | Position | Beginn |
---|---|---|
TWIST BIOSCIENCE CORPORATION | Chief Executive Officer | 01.04.2013 |
GENEDX HOLDINGS CORP. | Director/Board Member | 01.09.2020 |
NFX Capital Management LLC
NFX Capital Management LLC Investment ManagersFinance NFX Capital Management LLC (NFX Capital) is a venture capital firm founded in 2015. The firm is headquartered in San Francisco, California. | Consultant / Advisor | 01.02.2021 |
Pillar Co Management LLC
Pillar Co Management LLC Investment ManagersFinance Pillar Co Management LLC (Pillar VC) is a venture capital firm founded in 2016 by Jamie Goldstein. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | - |
Nuclear Threat Initiative, Inc.
Nuclear Threat Initiative, Inc. Miscellaneous Commercial ServicesCommercial Services Nuclear Threat Initiative, Inc. provides nuclear awareness. It designs threat reduction projects that show governments the way and build momentum and support for action. The company was founded in 1948 and is headquartered in Washington, WA. | Director/Board Member | 13.10.2023 |
Ehemalige bekannte Positionen von Emily Leproust
Unternehmen | Position | Ende |
---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.04.2013 |
SEM4 HLDG | Director/Board Member | - |
NEKTAR THERAPEUTICS | Chairman | - |
Petri
Petri Investment ManagersFinance Petri is a venture capital firm founded in 2019 by Andy Beck, Daphne Koller, Emily Leproust, Chris Voigt, Reshma Shetty, Alec Nielsen, Bernhard van Lengerich,Stan Lapidus, Pam Silver, JP Mangeolle and George Church. The firm is headquartered in Boston, MA. | Founder | - |
Ausbildung von Emily Leproust
University of Houston | Doctorate Degree |
Lyon School of Industrial Chemistry | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
AGILENT TECHNOLOGIES, INC. | Health Technology |
TWIST BIOSCIENCE CORPORATION | Health Technology |
GENEDX HOLDINGS CORP. | Health Services |
Private Unternehmen | 5 |
---|---|
Nuclear Threat Initiative, Inc.
Nuclear Threat Initiative, Inc. Miscellaneous Commercial ServicesCommercial Services Nuclear Threat Initiative, Inc. provides nuclear awareness. It designs threat reduction projects that show governments the way and build momentum and support for action. The company was founded in 1948 and is headquartered in Washington, WA. | Commercial Services |
NFX Capital Management LLC
NFX Capital Management LLC Investment ManagersFinance NFX Capital Management LLC (NFX Capital) is a venture capital firm founded in 2015. The firm is headquartered in San Francisco, California. | Finance |
Pillar Co Management LLC
Pillar Co Management LLC Investment ManagersFinance Pillar Co Management LLC (Pillar VC) is a venture capital firm founded in 2016 by Jamie Goldstein. The firm is headquartered in Boston, Massachusetts. | Finance |
Petri
Petri Investment ManagersFinance Petri is a venture capital firm founded in 2019 by Andy Beck, Daphne Koller, Emily Leproust, Chris Voigt, Reshma Shetty, Alec Nielsen, Bernhard van Lengerich,Stan Lapidus, Pam Silver, JP Mangeolle and George Church. The firm is headquartered in Boston, MA. | Finance |
CM Life Sciences, Inc.
CM Life Sciences, Inc. Financial ConglomeratesFinance CM Life Sciences, Inc. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on July 10, 2020 and is headquartered in New York, NY. | Finance |